Clinical Trial Update: A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rhPTH(1-84) in Japanese participants with chronic hypoparathyroidism was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• rhPTH(1-84) (recombinant human parathyroid hormone 1-84)

Snippet

Sponsor: Shire | Conditions: Chronic Hypoparathyroidism | Phase 3 | Status: WITHDRAWN